Part D Off-Label Prescription Parity Act
Official title: To amend title XVIII of the Social Security Act to permit coverage of certain covered part D drugs for uses that are determined to be for medically accepted in… Show full official titleShow less
Official title: To amend title XVIII of the Social Security Act to permit coverage of certain covered part D drugs for uses that are determined to be for medically accepted indications based upon clinical evidence in peer reviewed medical literature.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Part D Off-Label Prescription Parity Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to permit a prescription drug plan (PDP) sponsor offering a PDP or a MedicareAdvantage (MA) organization offering an MA-PD plan to offer coverage of covered part D drugs for uses that are determined to be for medically accepted indications based upon: (1) guidance provided by the Secretary of Health and Human Services (HHS) for determining accepted uses of covered part D drugs; and (2) supportive clinical evidence in peer reviewed medical literature.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 1055: Part D Off-Label Prescription Parity Act. 112th Congress. Open America. https://openamerica.io/bill/112-HR-1055/
"H.R. 1055: Part D Off-Label Prescription Parity Act." 112th Congress, 2026, Open America, https://openamerica.io/bill/112-HR-1055/.
H.R. 1055, 112th Cong. (2026), https://openamerica.io/bill/112-HR-1055/.
[H.R. 1055: Part D Off-Label Prescription Parity Act](https://openamerica.io/bill/112-HR-1055/)